1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. LABORATORY AUTOMATION MARKET BY COMPONENT
5.1. Introduction
5.2. Hardware
5.3. Software
5.4. Services
6. LABORATORY AUTOMATION MARKET BY AUTOMATION TYPE
6.1. Introduction
6.2. Modular
6.3. Fully-Automated
7. LABORATORY AUTOMATION MARKET BY APPLICATION
7.1. Introduction
7.2. Immunodiagnostics
7.3. Molecular Diagnostics
7.4. Drug Development
7.5. Hematology
7.6. Others
8. LABORATORY AUTOMATION MARKET BY END-USER
8.1. Introduction
8.2. Hospitals & Diagnostics Centers
8.3. Pharmaceutical & Biotechnology Companies
8.4. Research & Academic Institutes
9. LABORATORY AUTOMATION MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Italy
9.4.5. Spain
9.4.6. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Israel
9.5.4. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Taiwan
9.6.8. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Danaher Corporation
11.2. Abbott Laboratories
11.3. PerkinElmer, Inc.
11.4. Tecan Trading AG
11.5. Synchron
11.6. Hudson Robotics Inc.
11.7. F. Hoffmann- La Roche AG
11.8. Scienion AG
11.9. Thermo Fisher Scientific
11.10. COPAN ITALIA spa
11.11. Horiba, Ltd.
11.12. Oracle Corporation
11.13. HighRes Biosolutions
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES